Autologous Stem Cells(El-Rayadh Fertility Centre)(Autologous Stem Cells(El-Rayadh Fertility Centre))

概要

基本信息

药物类型

干细胞疗法

别名-

靶点-

作用方式-

作用机制

干细胞替代物

治疗领域

内分泌与代谢疾病泌尿生殖系统疾病

在研适应症-

非在研适应症

精子发生停滞原发性卵巢功能不全

原研机构

El-Rayadh Fertility Centre

在研机构-

非在研机构

El-Rayadh Fertility Centre

权益机构-

最高研发阶段无进展临床1/2期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

8

项与 Autologous Stem Cells(El-Rayadh Fertility Centre) 相关的临床试验

CTRI/2024/02/062437

/ Not yet recruiting临床2期IIT

Role of Autologous Stem Cells and Platelet Rich Plasma Therapy forRegenerating Endometrium in Women with Asherman’s Syndrome and Atrophic Endometrium-A Pilot Study

开始日期2024-02-18

申办/合作机构-

JPRN-jRCTb040230035

/ Recruiting临床1期IIT

A clinical study of bone regeneration using autologous dental pulp stem cells

开始日期2023-06-12

申办/合作机构-

JPRN-jRCT2033230017

/ RecruitingN/AIIT

A single-center, double-blind, placebo-controlled, randomized, parallel-group study to evaluate the efficacy and safety of Intraarticular injections of autologous synovial stem cells for knee osteoarthritis (Investigator initiated clinical trial) - Autologous synovial MSC injection into the OA knee

开始日期2023-04-03

申办/合作机构-

100 项与 Autologous Stem Cells(El-Rayadh Fertility Centre) 相关的临床结果

登录后查看更多信息

100 项与 Autologous Stem Cells(El-Rayadh Fertility Centre) 相关的转化医学

登录后查看更多信息

100 项与 Autologous Stem Cells(El-Rayadh Fertility Centre) 相关的专利（医药）

登录后查看更多信息

2

项与 Autologous Stem Cells(El-Rayadh Fertility Centre) 相关的文献（医药）

2021-12-01·Transfusion and Apheresis Science4区 · 医学

Intra-lesionally autologous stem cell application in diabetic foot/ulcer

4区 · 医学

Article

作者: Bolaman, Ali Zahit ; Yavasoglu, Irfan

The diabetic fot/ulcer is the cause of high morbidity and mortality in patients with diabetes mellitus (DM). Generally, medical treatment of diabetic foot/ulcer is ineffective and stem cell implantation is an important option in the treatment. Here, we present a 69 years old man admitted to hospital due to a 3 × 4 cm wound in the plantar surface of left foot. Autologous stem cells were applied intralesionally into diabetic ulcers. The lesion shrunken 50 % at the 16th week and there is a wound under the left foot at 32nd week. Intralesionally autologous stem cell application was useful and safe without adverse course in patients with diabetic foot/ulcer.

2010-03-01·Journal of Gastrointestinal Cancer

Stem Cell Therapy Improves the Outcome of Liver Resection in Cirrhotics

Article

作者: Alaa Ismail ; Ossama Fouad ; Abdulhafez Selim ; Andaleeb Chowdhury ; Amr Abdelnasser

INTRODUCTIONSignificant proportions of liver cirrhotic patients develop hepatocellular carcinoma and have to undergo hepatic resection. The compromised cirrhotic liver cannot withstand further removal of hepatic tissue, thus, leading to postoperative complication and death.METHODSIn this study, we enrolled 20 patients having liver cirrhosis with hepatocellular carcinoma and randomly assigned them into two groups to receive autologous stem cells or placebo.RESULTSAfter 3 weeks, all participants underwent liver resection and were followed for 12 weeks postoperative. We observed that the group receiving preoperative stem cell therapy had shown a significant improvement in all parameters of liver function and had no postoperative complications compared to the group treated with placebo, which showed no improvement in liver parameters and had postoperative complications.DISCUSSIONIn conclusion, autologous stem cell therapy can improve the surgical outcome in cirrhotic livers and should be considered as an adjuvant treatment in such patients undergoing hepatic resection.

100 项与 Autologous Stem Cells(El-Rayadh Fertility Centre) 相关的药物交易

登录后查看更多信息